학술논문
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study
Document Type
Article
Author
Abernethy, Rikki; Ahmad, Yasmeen; Akil, Mohamed; Bartram, Sarah; Batley, Mike; Bharadwaj, Anurag; Bruce, Ian; Carlucci, Francesco; Chan, Antoni; Dasgupta, Bhaskar; D'Cruz, David; De Lord, Denise; Dyke, Bernard; Edwards, Christopher; Erb, Nicola; Farrell, Adrian; Gayed, Mary; Gendi, Nagui; Gompels, Luke; Gordon, Caroline; Gordon, Patrick; Griffiths, Bridget; Gullick, Nicola; Gunwardena, Harsha; Haigh, Richard; Hamdulay, Shahir; Haque, Sahena; Hutchinson, David; Isenberg, David; Jayne, David; Jeffery, Rachel; Kapur, Deepti; Kaul, Arvind; King, Jon; Knights, Sally; Korendowych, Ellie; Lanyon, Peter; Mahindrakar, Madhu; Marks, Jonathan; McCann, Liza; McLaren, Zoe; Mediwake, Rapti; Menon, Ajit; Mewar, Devesh; Min, Steven Young; Nair, Jagdish; O'Riordan, Edmond; Pyne, Dev; Rahmeh, Fouz; Regan, Marian; Reynolds, John; Rhodes, Ben; Rhys-Dillon, Ceril; Robson, Joanna C; Shaffu, Shireen; Sheeran, T; Skeoch, Sarah; Sood, Bhrigu Raj; Stratton, Richard; Teh, Lee-Suan; Vermaak, Erin; Vital, Ed; Waller, Rosemary; Watts, Richard; Wijeyekoon, Jananath; Yee, Chee-Seng; Yong, Cee Yi; Youssef, Hazem; Yusuf, Abid; Zoma, Asad; Rodziewicz, Mia ; Dyball, Sarah ; Lunt, Mark; McDonald, Stephen; Sutton, Emily; Parker, Ben; Bruce, Ian N
Source
In The Lancet Rheumatology May 2023 5(5):e284-e292
Subject
Language
ISSN
2665-9913